Drug Interactions between Dexamethasone Intensol and Emtet-500
This report displays the potential drug interactions for the following 2 drugs:
- Dexamethasone Intensol (dexamethasone)
- Emtet-500 (tetracycline)
Interactions between your drugs
No interactions were found between Dexamethasone Intensol and Emtet-500. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Dexamethasone Intensol
A total of 828 drugs are known to interact with Dexamethasone Intensol.
- Dexamethasone intensol is in the drug class glucocorticoids.
-
Dexamethasone intensol is used to treat the following conditions:
- Addison's Disease
- Adrenal Insufficiency
- Adrenocortical Insufficiency
- Allergic Rhinitis
- Ankylosing Spondylitis
- Aspiration Pneumonia
- Asthma
- Asthma, acute
- Atopic Dermatitis
- Bronchopulmonary Dysplasia
- Bursitis
- Cerebral Edema
- Chorioretinitis
- Congenital Adrenal Hyperplasia
- Crohn's Disease, Active
- Croup
- Cushing's Syndrome
- Dermatitis Herpetiformis
- Eczema
- Epicondylitis, Tennis Elbow
- Erythroblastopenia
- Evan's Syndrome
- Gouty Arthritis
- Hemolytic Anemia
- Hypercalcemia of Malignancy
- Immune Thrombocytopenia
- Inflammatory Bowel Disease
- Inflammatory Conditions
- Iridocyclitis
- Iritis
- Juvenile Rheumatoid Arthritis
- Keratitis
- Leukemia
- Loeffler's Syndrome
- Lupus
- Lymphoma
- Meningitis, Haemophilus influenzae
- Meningitis, Listeriosis
- Meningitis, Meningococcal
- Meningitis, Pneumococcal
- Mountain Sickness / Altitude Sickness
- Multiple Myeloma
- Multiple Sclerosis
- Mycosis Fungoides
- Nausea/Vomiting, Chemotherapy Induced
- Neurosarcoidosis
- Psoriatic Arthritis
- Pulmonary Tuberculosis
- Rheumatoid Arthritis
- Sarcoidosis
- Seborrheic Dermatitis
- Shock
- Synovitis
- Thrombocytopenia
- Toxic Epidermal Necrolysis
- Tuberculous Meningitis
- Ulcerative Colitis
- Uveitis, Posterior
Emtet-500
A total of 225 drugs are known to interact with Emtet-500.
- Emtet-500 is in the drug class tetracyclines.
-
Emtet-500 is used to treat the following conditions:
- Acne
- Bacterial Infection
- Bladder Infection
- Bronchitis
- Brucellosis
- Bullous Pemphigoid
- Chlamydia Infection
- Ehrlichiosis
- Epididymitis, Sexually Transmitted
- Gonococcal Infection, Uncomplicated
- Helicobacter Pylori Infection
- Lyme Disease, Arthritis
- Lyme Disease, Carditis
- Lyme Disease, Erythema Chronicum Migrans
- Lyme Disease, Neurologic
- Lymphogranuloma Venereum
- Nongonococcal Urethritis
- Ocular Rosacea
- Ornithosis
- Pelvic Inflammatory Disease
- Pemphigoid
- Pneumonia
- Psittacosis
- Rickettsial Infection
- Syphilis, Early
- Syphilis, Latent
- Tertiary Syphilis
- Upper Respiratory Tract Infection
Drug and food/lifestyle interactions
tetracycline food/lifestyle
Applies to: Emtet-500 (tetracycline)
Do not take iron supplements, multivitamins, calcium supplements, antacids, or laxatives within 2 hours before or after taking tetracycline. These products can make tetracycline less effective in treating your infection. Do not take tetracycline with milk or other dairy products, unless your doctor has told you to. Dairy products can make it harder for your body to absorb the medication.
tetracycline food/lifestyle
Applies to: Emtet-500 (tetracycline)
Consumer information for this interaction is not currently available.
GENERALLY AVOID: The oral bioavailability of quinolone and tetracycline antibiotics may be reduced by concurrent administration of preparations containing polyvalent cations such as aluminum, calcium, iron, magnesium, and zinc. Therapeutic failure may result. The proposed mechanism is chelation of quinolone and tetracycline antibiotics by di- and trivalent cations, forming an insoluble complex that is poorly absorbed from the gastrointestinal tract. Reduced gastrointestinal absorption of the cations should also be considered.
MANAGEMENT: Concomitant administration of oral quinolone and tetracycline antibiotics with preparations containing aluminum, calcium, iron, magnesium, and/or zinc salts should generally be avoided. Otherwise, the times of administration should be staggered by as much as possible to minimize the potential for interaction. Quinolones should typically be dosed either 2 to 4 hours before or 4 to 6 hours after polyvalent cation preparations, depending on the quinolone and formulation. Likewise, tetracyclines and polyvalent cation preparations should typically be administered 2 to 4 hours apart. The prescribing information for the antibiotic should be consulted for more specific dosing recommendations.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.